These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 34423416

  • 21. Increased complications of chronic erythrocytapheresis compared with manual exchange transfusions in children and adolescents with sickle cell disease.
    Woods D, Hayashi RJ, Binkley MM, Sparks GW, Hulbert ML.
    Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28544309
    [Abstract] [Full Text] [Related]

  • 22. Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: A report from the multi-center study of iron overload.
    Fung EB, Harmatz P, Milet M, Ballas SK, De Castro L, Hagar W, Owen W, Olivieri N, Smith-Whitley K, Darbari D, Wang W, Vichinsky E, Multi-Center Study of Iron Overload Research Group.
    Am J Hematol; 2007 Apr; 82(4):255-65. PubMed ID: 17094096
    [Abstract] [Full Text] [Related]

  • 23. Severe cardiac iron toxicity in two adults with sickle cell disease.
    Oduor H, Minniti CP, Brofferio A, Gharib AM, Abd-Elmoniem KZ, Hsieh MM, Tisdale JF, Fitzhugh CD.
    Transfusion; 2017 Mar; 57(3):700-704. PubMed ID: 28019032
    [Abstract] [Full Text] [Related]

  • 24. Effectiveness of red blood cell exchange, partial manual exchange, and simple transfusion concurrently with iron chelation therapy in reducing iron overload in chronically transfused sickle cell anemia patients.
    Fasano RM, Leong T, Kaushal M, Sagiv E, Luban NL, Meier ER.
    Transfusion; 2016 Jul; 56(7):1707-15. PubMed ID: 26997031
    [Abstract] [Full Text] [Related]

  • 25. Progression of iron overload in sickle cell disease.
    Olivieri NF.
    Semin Hematol; 2001 Jan; 38(1 Suppl 1):57-62. PubMed ID: 11206962
    [Abstract] [Full Text] [Related]

  • 26. Ferritin trends do not predict changes in total body iron in patients with transfusional iron overload.
    Puliyel M, Sposto R, Berdoukas VA, Hofstra TC, Nord A, Carson S, Wood J, Coates TD.
    Am J Hematol; 2014 Apr; 89(4):391-4. PubMed ID: 24347294
    [Abstract] [Full Text] [Related]

  • 27. Approaches to transfusion therapy and iron overload in patients with sickle cell disease: results of an international survey.
    Vichinsky EP, Ohene-Frempong K, Transfusion Committee.
    Pediatr Hematol Oncol; 2011 Feb; 28(1):37-42. PubMed ID: 20673029
    [Abstract] [Full Text] [Related]

  • 28. Noninvasive methods for quantitative assessment of transfusional iron overload in sickle cell disease.
    Brittenham GM, Sheth S, Allen CJ, Farrell DE.
    Semin Hematol; 2001 Jan; 38(1 Suppl 1):37-56. PubMed ID: 11206960
    [Abstract] [Full Text] [Related]

  • 29. Iron chelation therapy for patients with sickle cell disease and iron overload.
    Inati A, Khoriaty E, Musallam KM, Taher AT.
    Am J Hematol; 2010 Oct; 85(10):782-6. PubMed ID: 20721892
    [No Abstract] [Full Text] [Related]

  • 30. Serum ferritin underestimates liver iron concentration in transfusion independent thalassemia patients as compared to regularly transfused thalassemia and sickle cell patients.
    Pakbaz Z, Fischer R, Fung E, Nielsen P, Harmatz P, Vichinsky E.
    Pediatr Blood Cancer; 2007 Sep; 49(3):329-32. PubMed ID: 17554789
    [Abstract] [Full Text] [Related]

  • 31. Transfusional Iron Overload in a Cohort of Children with Sickle Cell Disease: Impact of Magnetic Resonance Imaging, Transfusion Method, and Chelation.
    Stanley HM, Friedman DF, Webb J, Kwiatkowski JL.
    Pediatr Blood Cancer; 2016 Aug; 63(8):1414-8. PubMed ID: 27100139
    [Abstract] [Full Text] [Related]

  • 32. Safety and efficacy of high dose intravenous desferrioxamine for reduction of iron overload in sickle cell disease.
    Kalpatthi R, Peters B, Kane I, Holloman D, Rackoff E, Disco D, Jackson S, Laver JH, Abboud MR.
    Pediatr Blood Cancer; 2010 Dec 15; 55(7):1338-42. PubMed ID: 20981690
    [Abstract] [Full Text] [Related]

  • 33. Iron-chelating therapy for transfusional iron overload.
    Taccone-Gallucci M, Manca-di-Villahermosa S, Noce A.
    N Engl J Med; 2011 Apr 14; 364(15):1476-7; author reply 1477. PubMed ID: 21488786
    [No Abstract] [Full Text] [Related]

  • 34. Partial manual exchange reduces iron accumulation during chronic red cell transfusions for sickle cell disease.
    Savage WJ, Reddoch S, Wolfe J, Casella JF.
    J Pediatr Hematol Oncol; 2013 Aug 14; 35(6):434-6. PubMed ID: 23887022
    [Abstract] [Full Text] [Related]

  • 35. Iron overload is a determinant of morbidity and mortality in adult patients with sickle cell disease.
    Ballas SK.
    Semin Hematol; 2001 Jan 14; 38(1 Suppl 1):30-6. PubMed ID: 11206959
    [Abstract] [Full Text] [Related]

  • 36. A pilot study of manual chronic partial exchange transfusion in children with sickle disease.
    Aloni MN, Lê PQ, Heijmans C, Huybrechts S, Devalck C, Azzi N, Ngalula-Mujinga M, Ferster A.
    Hematology; 2015 Jun 14; 20(5):284-8. PubMed ID: 25133935
    [Abstract] [Full Text] [Related]

  • 37. Iron-chelating therapy for transfusional iron overload.
    Musallam KM, Taher AT.
    N Engl J Med; 2011 Apr 14; 364(15):1476; author reply 1477. PubMed ID: 21488787
    [No Abstract] [Full Text] [Related]

  • 38. An assessment of iron overload in children treated for cancer and nonmalignant hematologic disorders.
    Rascon J, Rageliene L, Stankeviciene S, Palionis D, Tamosiunas AE, Valeviciene N, Zvirblis T.
    Eur J Pediatr; 2014 Sep 14; 173(9):1137-46. PubMed ID: 24659311
    [Abstract] [Full Text] [Related]

  • 39. Study of gonadal hormones in Egyptian female children with sickle cell anemia in correlation with iron overload: Single center study.
    Hagag AA, El-Farargy MS, Elrefaey S, Abo El-enein AM.
    Hematol Oncol Stem Cell Ther; 2016 Mar 14; 9(1):1-7. PubMed ID: 26684919
    [Abstract] [Full Text] [Related]

  • 40. Deferasirox in children with transfusion-dependent thalassemia or sickle cell anemia: A large cohort real-life experience from Turkey (REACH-THEM).
    Antmen B, Karakaş Z, Yeşilipek MA, Küpesiz OA, Şaşmaz İ, Uygun V, Kurtoğlu E, Oktay G, Aydogan G, Akın M, Salcioglu Z, Vergin C, Kazancı EG, Ünal S, Çalışkan Ü, Aral YZ, Türkkan E, Meral Güneş A, Tunç B, Gümrük F, Ayhan AC, Söker M, Koç A, Oymak Y, Ertem M, Timur Ç, Yıldırmak Y, İrken G, Apak H, Biner B, Eren TG, Işık Balcı Y, Koçak Ü, Karasu G, Akkaynak D, Patıroğlu T.
    Eur J Haematol; 2019 Feb 14; 102(2):123-130. PubMed ID: 30300449
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.